Home Newsletters Mesenchymal Cell News Exosomes Derived from Human Amniotic Mesenchymal Stem Cells Facilitate Diabetic Wound Healing...

Exosomes Derived from Human Amniotic Mesenchymal Stem Cells Facilitate Diabetic Wound Healing by Angiogenesis and Enrich Multiple lncRNAs

0
The effect of exosomes derived from human amniotic MSCs (hAMSC-Exos) on diabetic wound healing were tested by measuring wound closure rates and immunohistochemical staining of CD31.
[Tissue Engineering And Regenerative Medicine]
Abstract
Exit mobile version